The expression and function of microRNAs in bone homeostasis

Frontiers in Bioscience - Landmark

Volumn 20, Issue 1, 2015, Pages 119-138

  Pi, Caixia ^a,b   Li, Yi Ping ^c   Zhou, Xuedong ^a,b   Gao, Bo ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c University of Alabama at Birmingham   (United States)

Author keywords

Bone Homeostasis; microRNAs; Osteoblast; Osteoclast; Review

Indexed keywords

MICRORNA;

BONE; BONE DEVELOPMENT; GENETICS; HOMEOSTASIS; HUMAN; PHYSIOLOGY;

BONE AND BONES; HOMEOSTASIS; HUMANS; MICRORNAS; OSTEOGENESIS;

EID: 84918835241     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4301     Document Type: Review

References (89)

1. J. B. Lian, G. S. Stein, A. J. van Wijnen, J. L. Stein, M. Q. Hassan, T. Gaur and Y. Zhang: MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8 (4), 212-27 (2012) DOI:10.1038/nrendo.2011.234
2. S. Dong, B. Yang, H. Guo and F. Kang: MicroRNAs regulate osteogenesis and chondrogenesis. Biochem Biophys Res Commun 418 (4), 587-91 (2012) DOI:10.1016/j.bbrc.2012.01.075
3. Y. Wang, Y. P. Li, C. Paulson, J. Z. Shao, X. Zhang, M. Wu and W. Chen: Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed) 19, 379-407 (2014) DOI: 10.2741/4214
4. V. Ambros: The functions of animal microRNAs. Nature 431 (7006), 350-5 (2004) DOI: 10.1038/nature02871
5. T. Nakasa, H. Shibuya, Y. Nagata, T. Niimoto and M. Ochi: The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 63 (6), 1582-90 (2011) DOI: 10.1002/art.30321
6. F. Wahid, A. Shehzad, T. Khan and Y. Y. Kim: MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 1803 (11), 1231-43 (2010) DOI: 10.1016/j.bbamcr.2010.06.013
7. J. R. Lytle, T. A. Yario and J. A. Steitz: Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104 (23), 9667-72 (2007) DOI: 10.1073/pnas.0703820104
8. R. C. Friedman, K. K. Farh, C. B. Burge and D. P. BarTel: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19 (1), 92-105 (2009) DOI: 10.1101/gr.082701.108
9. N. A. Sims and J. H. Gooi: Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 19 (5), 444-51 (2008) DOI: 10.1016/j.semcdb.2008.07.016
10. E. D. Jensen, R. Gopalakrishnan and J. J. Westendorf: Regulation of gene expression in osteoblasts. Biofactors 36 (1), 25-32 (2010) DOI: 10.1002/biof.72
11. R. Hu, H. Li, W. Liu, L. Yang, Y. F. Tan and X. H. Luo: Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets 14 (10), 1109-20 (2010) DOI: 10.1517/14728222.2010.512916
12. N. Zamurovic, D. Cappellen, D. Rohner and M. Susa: Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 279 (36), 37704-15 (2004) DOI: 10.1074/jbc.M403813200
13. S. Zhou, S. Mizuno and J. Glowacki: Wnt pathway regulation by demineralized bone is approximated by both BMP-2 and TGF-beta1 signaling. J Orthop Res 31 (4), 554-60 (2013) DOI: 10.1002/jor.22244
14. M. Takigawa: CCN2: a master regulator of the genesis of bone and cartilage. J Cell Commun Signal 7 (3), 191-201 (2013) DOI: 10.1007/s12079-013-0204-8
15. Q. Liu, Q. Wan, R. Yang, H. Zhou and Z. Li: Effects of intermittent versus continuous parathyroid hormone administration on condylar chondrocyte proliferation and differentiation. Biochem Biophys Res Commun 424 (1), 182-8 (2012) DOI: 10.1016/j.bbrc.2012.06.106
16. W. Wang, N. Lian, L. Li, H. E. Moss, D. S. Perrien, F. Elefteriou and X. Yang: Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development 136 (24), 4143-53 (2009) DOI: 10.1242/dev.043281
17. M. Wuelling and A. Vortkamp: Chondrocyte proliferation and differentiation. Endocr Dev 21, 1-11 (2011) DOI: 10.1159/000328081
18. M. Asagiri and H. Takayanagi: The molecular understanding of osteoclast differentiation. Bone 40 (2), 251-64 (2007) DOI: 10.1016/j.bone.2006.09.023
19. K. Henriksen, A. V. Neutzsky-Wulff, L. F. Bonewald and M. A. Karsdal: Local communication on and within bone controls bone remodeling. Bone 44 (6), 1026-33 (2009) DOI: 10.1016/j.bone.2009.03.671
20. W. Chen, G. Zhu, L. Hao, M. Wu, H. Ci and Y. P. Li: C/EBPalpha regulates osteoclast lineage commitment. Proc Natl Acad Sci U S A 110 (18), 7294-9 (2013) DOI: 10.1073/pnas.1211383110
21. A. Arai, T. Mizoguchi, S. Harada, Y. Kobayashi, Y. Nakamichi, H. Yasuda, J. M. Penninger, K. Yamada, N. Udagawa and N. Takahashi: Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. J Cell Sci 125 (Pt 12), 2910-7 (2012) DOI: 10.1242/jcs.099986
22. L. F. Bonewald: The amazing osteocyte. J Bone Miner Res 26 (2), 229-38 (2011) DOI: 10.1002/jbmr.320
23. J. M. Graham, B. P. Ayati, S. A. Holstein and J. A. Martin: The role of osteocytes in targeted bone remodeling: a mathematical model. PLoS One 8 (5), e63884 (2013) DOI: 10.1371/journal.pone.0063884
24. C. A. O'Brien, T. Nakashima and H. Takayanagi: Osteocyte control of osteoclastogenesis. Bone 54 (2), 258-63 (2013) DOI: 10.1016/j.bone.2012.08.121
25. T. Maurin, D. Cazalla, S. Yang, Jr., D. Bortolamiol-Becet and E. C. Lai: RNase III-independent microRNA biogenesis in mammalian cells. RNA 18 (12), 2166-73 (2012) DOI: 10.1261/rna.036194.112
26. S. J. Lee, C. Jiko, E. Yamashita and T. Tsukihara: Selective nuclear export mechanism of small RNAs. Curr Opin Struct Biol 21 (1), 101-8 (2011) DOI: 10.1016/j.sbi.2010.11.004
27. K. Kapinas and A. M. Delany: MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther 13 (3), 220 (2011) DOI: 10.1186/ar3325
28. L. Guo and Z. Lu: The fate of miRNA∗ strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? PLoS One 5 (6), e11387 (2010) DOI: 10.1371/journal.pone.0011387
29. K. Okamura, M. D. Phillips, D. M. Tyler, H. Duan, Y. T. Chou and E. C. Lai: The regulatory activity of microRNA∗ species has substantial influence on microRNA and 3' UTR evolution. Nat Struct Mol Biol 15 (4), 354-63 (2008) DOI: 10.1038/nsmb.1409
30. K. W. Chang, S. Y. Kao, Y. H. Wu, M. M. Tsai, H. F. Tu, C. J. Liu, M. T. Lui and S. C. Lin: Passenger strand miRNA miR-31∗ regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol 49 (1), 27-33 (2013) DOI: 10.1016/j.oraloncology.2012.07.003
31. G. Di Leva and C. M. Croce: Roles of small RNAs in tumor formation. Trends Mol Med 16 (6), 257-67 (2010) DOI: 10.1016/j.molmed.2010.04.001
32. K. B. Jones, Z. Salah, S. Del Mare, M. Galasso, E. Gaudio, G. J. Nuovo, F. Lovat, K. LeBlanc, J. Palatini, R. L. Randall, S. Volinia, G. S. Stein, C. M. Croce, J. B. Lian and R. I. Aqeilan: miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 72 (7), 1865-77 (2012) DOI: 10.1158/0008-5472.CAN-11-2663
33. J. Liu, M. Zheng, Y. L. Tang, X. H. Liang and Q. Yang: MicroRNAs, an active and versatile group in cancers. Int J Oral Sci 3 (4), 165-75 (2011) DOI: 10.4248/IJOS11063
34. A. J. van Wijnen, J. van de Peppel, J. P. van Leeuwen, J. B. Lian, G. S. Stein, J. J. Westendorf, M. J. Oursler, H. J. Im, H. Taipaleenmaki, E. Hesse, S. Riester and S. Kakar: MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep 11 (2), 72-82 (2013) DOI: 10.1007/s11914-013-0143-6
35. A. Rakian, W. C. Yang, J. Gluhak- Heinrich, Y. Cui, M. A. Harris, D. Villarreal, J. Q. Feng, M. Macdougall and S. E. Harris: Bone morphogenetic protein-2 gene controls tooth root development in coordination with formation of the periodontium. Int J Oral Sci 5 (2), 75-84 (2013) DOI: 10.1038/ijos.2013.41
36. Y. Bae, T. Yang, H. C. Zeng, P. M. Campeau, Y. Chen, T. Bertin, B. C. Dawson, E. Munivez, J. Tao and B. H. Lee: miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 21 (13), 2991-3000 (2012) DOI: 10.1093/hmg/dds129
37. E. Canalis, D. J. Adams, A. Boskey, K. Parker, L. Kranz and S. Zanotti: Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. J Biol Chem 288 (35), 25614-25 (2013) DOI: 10.1074/jbc.M113.470492
38. Y. Zhang, R. L. Xie, C. M. Croce, J. L. Stein, J. B. Lian, A. J. van Wijnen and G. S. Stein: A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A 108 (24), 9863-8 (2011) DOI: 10.1073/pnas.1018493108
39. Y. Zhang, R. L. Xie, J. Gordon, K. LeBlanc, J. L. Stein, J. B. Lian, A. J. van Wijnen and G. S. Stein: Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem 287 (26), 21926-35 (2012) DOI: 10.1074/jbc.M112.340398
40. M. Q. Hassan, J. A. Gordon, M. M. Beloti, C. M. Croce, A. J. van Wijnen, J. L. Stein, G. S. Stein and J. B. Lian: A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 107 (46), 19879-84 (2010) DOI: 10.1073/pnas.1007698107
41. E. J. Kim, I. H. Kang, J. W. Lee, W. G. Jang and J. T. Koh: MiR-433 mediates ERRgamma-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells. Life Sci 92 (10), 562-8 (2013) DOI: 10.1016/j.lfs.2013.01.015
42. G. Song and L. Wang: A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One 4 (11), e7829 (2009) DOI: 10.1371/journal.pone.0007829
43. W. G. Jang, E. J. Kim, I. H. Bae, K. N. Lee, Y. D. Kim, D. K. Kim, S. H. Kim, C. H. Lee, R. T. Franceschi, H. S. Choi and J. T. Koh: Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone 48 (4), 885-93 (2011) DOI: 10.1016/j.bone.2010.12.003
44. T. Wu, H. Zhou, Y. Hong, J. Li, X. Jiang and H. Huang: miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 287 (10), 7503-11 (2012) DOI: 10.1074/jbc.M111.292722
45. X. H. Li, C. T. Ha, D. Fu and M. Xiao: Micro-RNA30c negatively regulates REDD1 expression in human hematopoietic and osteoblast cells after gamma-irradiation. PLoS One 7 (11), e48700 (2012) DOI: 10.1371/journal.pone.0048700
46. A. Moorthi, S. Vimalraj, C. Avani, Z. He, N. C. Partridge and N. Selvamurugan: Expression of microRNA-30c and its target genes in human osteoblastic cells by nano-bioglass ceramic-treatment. Int J Biol Macromol 56, 181-5 (2013) DOI: 10.1016/j.ijbiomac.2013.02.017
47. T. Eguchi, K. Watanabe, E. S. Hara, M. Ono, T. Kuboki and S. K. Calderwood: OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One 8 (3), e58796 (2013) DOI: 10.1371/journal.pone.0058796
48. Z. Li, M. Q. Hassan, S. Volinia, A. J. van Wijnen, J. L. Stein, C. M. Croce, J. B. Lian and G. S. Stein: A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 105 (37), 13906-11 (2008) DOI: 10.1073/pnas.0804438105
49. H. Inose, H. Ochi, A. Kimura, K. Fujita, R. Xu, S. Sato, M. Iwasaki, S. Sunamura, Y. Takeuchi, S. Fukumoto, K. Saito, T. Nakamura, H. Siomi, H. Ito, Y. Arai, K. Shinomiya and S. Takeda: A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A 106 (49), 20794-9 (2009) DOI: 10.1073/pnas.0909311106
50. T. Itoh, M. Ando, Y. Tsukamasa and Y. Akao: Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse preosteoblast differentiation is regulated by microRNA-370. FEBS Lett 586 (12), 1693-701 (2012) DOI: 10.1016/j.febslet.2012.04.014
51. T. Itoh, S. Takeda and Y. Akao: MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. J Biol Chem 285 (36), 27745-52 (2010) DOI: 10.1074/jbc.M110.105080
52. T. Itoh, Y. Nozawa and Y. Akao: MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 284 (29), 19272-9 (2009) DOI: 10.1074/jbc.M109.014001
53. A. S. Zanetti, C. Sabliov, J. M. Gimble and D. J. Hayes: Human adipose-derived stem cells and three-dimensional scaffold constructs: a review of the biomaterials and models currently used for bone regeneration. J Biomed Mater Res B Appl Biomater 101 (1), 187-99 (2013) DOI: 10.1002/jbm.b.32817
54. S. Akiyoshi, T. Fukagawa, H. Ueo, M. Ishibashi, Y. Takahashi, M. Fabbri, M. Sasako, Y. Maehara, K. Mimori and M. Mori: Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer 107 (8), 1345-53 (2012) DOI: 10.1038/bjc.2012.326
55. Y. Zeng, X. Qu, H. Li, S. Huang, S. Wang, Q. Xu, R. Lin, Q. Han, J. Li and R. C. Zhao: MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett 586 (16), 2375-81 (2012) DOI: 10.1016/j.febslet.2012.05.049
56. H. Li, T. Li, S. Wang, J. Wei, J. Fan, J. Li, Q. Han, L. Liao, C. Shao and R. C. Zhao: miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 10 (3), 313-24 (2013) DOI:10.1016/j.scr.2012.11.007
57. J. F. Zhang, W. M. Fu, M. L. He, H. Wang, W. M. Wang, S. C. Yu, X. W. Bian, J. Zhou, M. C. Lin, G. Lu, W. S. Poon and H. F. Kung: MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 22 (21), 3955-61 (2011) DOI: 10.1091/mbc.E11-04-0356
58. E. Luzi, F. Marini, S. C. Sala, I. Tognarini, G. Galli and M. L. Brandi: Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 23 (2), 287-95 (2008) DOI: 10.1359/jbmr.071011
59. E. Luzi, F. Marini, I. Tognarini, G. Galli, A. Falchetti and M. L. Brandi: The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. Nucleic Acid Ther 22 (2), 103-8 (2012) DOI: 10.1089/nat.2012.0350 PMCID: PMC3426230
60. K. M. Kim, S. J. Park, S. H. Jung, E. J. Kim, G. Jogeswar, J. Ajita, Y. Rhee, C. H. Kim and S. K. Lim: miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res 27 (8), 1669-79 (2012) DOI: 10.1002/jbmr.1604
61. L. Yang, P. Cheng, C. Chen, H. B. He, G. Q. Xie, H. D. Zhou, H. Xie, X. P. Wu and X. H. Luo: miR-93/Sp7 function loop mediates osteoblast mineralization. J Bone Miner Res 27 (7), 1598-606 (2012) DOI: 10.1002/jbmr.1621
62. X. Wang, B. Guo, Q. Li, J. Peng, Z. Yang, A. Wang, D. Li, Z. Hou, K. Lv, G. Kan, H. Cao, H. Wu, J. Song, X. Pan, Q. Sun, S. Ling, Y. Li, M. Zhu, P. Zhang, S. Peng, X. Xie, T. Tang, A. Hong, Z. Bian, Y. Bai, A. Lu, F. He and G. Zhang: miR-214 targets ATF4 to inhibit bone formation. Nat Med 19 (1), 93-100 (2013) DOI: 10.1038/nm.3026
63. R. Bhushan, J. Grunhagen, J. Becker, P. N. Robinson, C. E. Ott and P. Knaus: miR-181a promotes osteoblastic differentiation through repression of TGF-beta signaling molecules. Int J Biochem Cell Biol 45 (3), 696-705 (2013) DOI: 10.1016/j.biocel.2012.12.008
64. Y. Mizuno, Y. Tokuzawa, Y. Ninomiya, K. Yagi, Y. Yatsuka-Kanesaki, T. Suda, T. Fukuda, T. Katagiri, Y. Kondoh, T. Amemiya, H. Tashiro and Y. Okazaki: miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 583 (13), 2263-8 (2009) DOI: 10.1016/j.febslet.2009.06.006
65. Y. Mizuno, K. Yagi, Y. Tokuzawa, Y. Kanesaki-Yatsuka, T. Suda, T. Katagiri, T. Fukuda, M. Maruyama, A. Okuda, T. Amemiya, Y. Kondoh, H. Tashiro and Y. Okazaki: miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368 (2), 267-72 (2008) DOI: 10.1016/j.bbrc.2008.01.073
66. H. Li, H. Xie, W. Liu, R. Hu, B. Huang, Y. F. Tan, K. Xu, Z. F. Sheng, H. D. Zhou, X. P. Wu and X. H. Luo: A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119 (12), 3666-77 (2009) DOI: 10.1172/JCI39832
67. R. Hu, W. Liu, H. Li, L. Yang, C. Chen, Z. Y. Xia, L. J. Guo, H. Xie, H. D. Zhou, X. P. Wu and X. H. Luo: A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286 (14), 12328-39 (2011) DOI: 10.1074/jbc.M110.176099
68. B. Gamez, E. Rodriguez-Carballo, R. Bartrons, J. L. Rosa and F. Ventura: MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem 288 (20), 14264-75 (2013) DOI: 10.1074/jbc.M112.432104
69. J. Guo, F. Ren, Y. Wang, S. Li, Z. Gao, X. Wang, H. Ning, J. Wu, Y. Li, Z. Wang, S. M. Chim, J. Xu and Z. Chang: miR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression. J Bone Miner Res 27 (7), 1607-18 (2012) DOI: 10.1002/jbmr.1597
70. J. Zhang, Q. Tu, L. F. Bonewald, X. He, G. Stein, J. Lian and J. Chen: Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res 26 (8), 1953-63 (2011) DOI: 10.1002/jbmr.377
71. T. Wang and Z. Xu: miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 402 (2), 186-9 (2010) DOI: 10.1016/j.bbrc.2010.08.031
72. M. Q. Hassan, Y. Maeda, H. Taipaleenmaki, W. Zhang, M. Jafferji, J. A. Gordon, Z. Li, C. M. Croce, A. J. van Wijnen, J. L. Stein, G. S. Stein and J. B. Lian: miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 287 (50), 42084-92 (2012) DOI: 10.1074/jbc.M112.377515
73. W. B. Zhang, W. J. Zhong and L. Wang: A signal-amplification circuit between miR-218 and Wnt/beta-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone 58, 59-66 (2014) DOI: 10.1016/j.bone.2013.09.015
74. I. Gay, A. Cavender, D. Peto, Z. Sun, A. Speer, H. Cao and B. A. Amendt: Differentiation of human dental stem cells reveals a role for microRNA-218. J Periodontal Res 49 (1), 110-120 (2014) DOI: 10.1111/jre.12086
75. K. Kapinas, C. Kessler, T. Ricks, G. Gronowicz and A. M. Delany: miR- 29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285 (33), 25221-31 (2010) DOI: 10.1074/jbc.M110.116137
76. Z. Li, M. Q. Hassan, M. Jafferji, R. I. Aqeilan, R. Garzon, C. M. Croce, A. J. van Wijnen, J. L. Stein, G. S. Stein and J. B. Lian: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284 (23), 15676-84 (2009) DOI: 10.1074/jbc.M809787200
77. M. Rossi, M. R. Pitari, N. Amodio, M. T. Di Martino, F. Conforti, E. Leone, C. Botta, F. M. Paolino, T. Del Giudice, E. Iuliano, M. Caraglia, M. Ferrarini, A. Giordano, P. Tagliaferri and P. Tassone: miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol 228 (7), 1506-15 (2013) DOI: 10.1002/jcp.24306
78. M. Mann, O. Barad, R. Agami, B. Geiger and E. Hornstein: miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci U S A 107 (36), 15804-9 (2010) DOI: 10.1073/pnas.0915022107
79. F. Mizoguchi, Y. Izu, T. Hayata, H. Hemmi, K. Nakashima, T. Nakamura, S. Kato, N. Miyasaka, Y. Ezura and M. Noda: Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 109 (5), 866-75 (2010) DOI: 10.1002/jcb.22228
80. T. Sugatani and K. A. Hruska: Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 284 (7), 4667-78 (2009) DOI: 10.1074/jbc.M805777200
81. T. Kagiya and S. Nakamura: Expression profiling of microRNAs in RAW264.7. cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodontal Res 48 (3), 373-85 (2013) DOI: 10.1111/jre.12017
82. T. Sugatani and K. A. Hruska: MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem 101 (4), 996-9 (2007) DOI: 10.1002/jcb.21335
83. T. Sugatani, J. Vacher and K. A. Hruska: A microRNA expression signature of osteoclastogenesis. Blood 117 (13), 3648-57 (2011) DOI: 10.1182/blood-2010-10-311415
84. J. Zhang, H. Zhao, J. Chen, B. Xia, Y. Jin, W. Wei, J. Shen and Y. Huang: Interferon-beta-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett 586 (19), 3255-62 (2012) DOI: 10.1016/j.febslet.2012.06.047
85. S. Bluml, M. Bonelli, B. Niederreiter, A. Puchner, G. Mayr, S. Hayer, M. I. Koenders, W. B. van den Berg, J. Smolen and K. Redlich: Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 63 (5), 1281-8 (2011) DOI: 10.1002/art.30281
86. F. Mizoguchi, Y. Murakami, T. Saito, N. Miyasaka and H. Kohsaka: miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 15 (5), R102 (2013) DOI: 10.1186/ar4282
87. Y. Lee, H. J. Kim, C. K. Park, Y. G. Kim, H. J. Lee, J. Y. Kim and H. H. Kim: MicroRNA-124 regulates osteoclast differentiation. Bone 56 (2), 383-9 (2013) DOI: 10.1016/j.bone.2013.07.007
88. Z. Xia, C. Chen, P. Chen, H. Xie and X. Luo: MicroRNAs and their roles in osteoclast differentiation. Front Med 5 (4), 414-9 (2011) DOI: 10.1007/s11684-011-0168-0
89. C. Chen, P. Cheng, H. Xie, H. D. Zhou, X. P. Wu, E. Y. Liao and X. H. Luo: MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res (2013)